Cargando…
Comparison Between First Line Target Therapy and Immunotherapy in Different Prognostic Categories of BRAF Mutant Metastatic Melanoma Patients: An Italian Melanoma Intergroup Study
BACKGROUND: BRAF and MEK inhibitors target therapies (TT) and AntiPD1 immunotherapies (IT) are available first-line treatments for BRAF v600 mutant metastatic melanoma patients. ECOG PS (E), baseline LDH (L), and baseline number of metastatic sites (N) are well-known clinical prognostic markers that...
Autores principales: | Marconcini, Riccardo, Fava, Paolo, Nuzzo, Amedeo, Manacorda, Simona, Ferrari, Marco, De Rosa, Francesco, De Tursi, Michele, Tanda, Enrica Teresa, Consoli, Francesca, Minisini, Alessandro, Pimpinelli, Nicola, Morgese, Francesca, Bersanelli, Melissa, Tucci, Marco, Saponara, Maristella, Parisi, Alessandro, Ocelli, Marcella, Bazzurri, Serena, Massaro, Giulia, Morganti, Riccardo, Ciardetti, Isabella, Stanganelli, Ignazio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421680/ https://www.ncbi.nlm.nih.gov/pubmed/36046043 http://dx.doi.org/10.3389/fonc.2022.917999 |
Ejemplares similares
-
No Impact of NRAS Mutation on Features of Primary and Metastatic Melanoma or on Outcomes of Checkpoint Inhibitor Immunotherapy: An Italian Melanoma Intergroup (IMI) Study
por: Guida, Michele, et al.
Publicado: (2021) -
Predictors of germline status for hereditary melanoma: 5 years of multi-gene panel testing within the Italian Melanoma Intergroup
por: Bruno, W., et al.
Publicado: (2022) -
Retrospective Chart Review of Dabrafenib Plus Trametinib in Patients with Metastatic BRAF V600-Mutant Melanoma Treated in the Individual Patient Program (DESCRIBE Italy)
por: Aglietta, Massimo, et al.
Publicado: (2021) -
Combination of immunotherapy and other targeted therapies in advanced cutaneous melanoma
por: Marconcini, Riccardo, et al.
Publicado: (2021) -
Vitamin D and the Risk of Non-Melanoma Skin Cancer: A Systematic Literature Review and Meta-Analysis on Behalf of the Italian Melanoma Intergroup
por: Caini, Saverio, et al.
Publicado: (2021)